Qingjian Li

Qingjian Li

Auto-generated profile, based on publicly available information

Qingjian Li

Department of Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2023 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
QLQingjian Li
Qingjian Li
JXJiaqi Xu
Jiaqi Xu
QSQianshu Sun
Qianshu Sun
ZZZebang Zhang
Zebang Zhang
YHYuanjia Hu
Yuanjia Hu
HYHerui Yao
Herui Yao

25 July 2025 in Science Advances
Verified
Journal Article
Open access
JLJingxin Liu
Jingxin Liu
CZCai Zhao
Cai Zhao
JCJiahao Chen
Jiahao Chen
PZPengguihang Zeng
Pengguihang Zeng
QLQingjian Li
Qingjian Li
JDJunjun Ding
Junjun Ding
Breast cancer is the most common malignancy in females and remains the leading cause of cancer-related deaths for women worldwide. The cellular and molecular basis of breast tumorigenesis is not completely understood partly due to the lack of human research models which simulate the development of breast cancer. Here, we developed a method for generating functional mammary-like cells (MCs) from human-induced pluripotent stem cells (iPSCs). The iPSC-MCs closely resemble human primary MCs at cellular, transcriptional, and functional levels. Using this method, a breast cancer model was generated using patient-derived iPSCs harboring germline BRCA1 mutation. The patient iPSC-MCs recapitulated the transcriptome, clinical genomic alteration, and tumorigenic ability of breast cancer cells. We also identified S100P as an oncogene downstream of mutated BRCA1 that promotes cancer cell stemness and tumorigenesis. Our study establishes a promising system of breast cancer for studying the mechanism of tumorigenesis and identifying potential therapeutic targets.